SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-133615
Filing Date
2022-04-29
Accepted
2022-04-29 16:07:30
Documents
4
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d307415ddef14a.htm DEF 14A 314557
2 GRAPHIC g307415g36p10.jpg GRAPHIC 197753
3 GRAPHIC g307415g37p19.jpg GRAPHIC 40127
4 GRAPHIC g307415g81k15.jpg GRAPHIC 55398
  Complete submission text file 0001193125-22-133615.txt   703695
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39634 | Film No.: 22875302
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences